A STUDY published in the US
this week has found that
hydrochlorothiazide is much less
effective than other blood pressure
drugs, and could give hypertension
patients a “false sense of security”.
Researchers at the St Luke’s-
Roosevelt Hospital in New York
reviewed previous studies and
found that thiazides lowered blood
pressure by only about half as
much as beta blockers and ACE
inhibitors.
In the 19 studies reviewed, low
doses of hydrochlorothiazide
reduced systolic blood pressure by
6.5 points on average, compared to
11.2 points for beta blcokers, 11
points for calcium channel blockers,
and ACE inhibitors by 12.9 points.
Lead scientist Franz Messerli said
the results showed that
hydrochlorothiazide should not be
used alone to lower blood pressure.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.